<think>
Okay, let's tackle this problem. The user wants me to extract structured data from a free-text histopathology report of prostate cancer. The output needs to be in JSON format with three specific fields: Sampletype, Malignancy, and Gleason. 

First, I need to determine the sample type. The allowed values are "biopsy", "RP", "TURP", or "NA". Looking at the provided text: "Tutkittavana edustavaa prostatakudosta sovituista paikoista." The term "prostatakudosta sovituista paikoista" translates to something like "representative prostate tissue from specified locations." There's no mention of biopsy, RP (radical prostatectomy), or TURP (transurethral resection of the prostate). So maybe the sample type isn't specified here. But wait, sometimes "edustavaa prostatakudosta" might imply a biopsy, but I'm not sure. The example given in the instructions used "biopsy" when the text mentioned "Prostata biopsiasta". Here, there's no explicit mention of biopsy, RP, or TURP. So perhaps the sample type is "NA" here.

Next, checking for malignancy. The allowed values are "kyllä", "ei", or "NA". The text mentions "rauhasrakenteita ja jonkin verran aaltoilevaa epiteeliä" which translates to glandular structures and some undulating epithelium. There's no mention of adenocarcinoma or malignancy indicators. The conclusion is still pending: "Loppupäätelmä on vielä kesken ja valmistuu lähipäivinä." So the final diagnosis isn't ready yet. Since the report doesn't confirm malignancy and the conclusion is pending, the malignancy field should be "NA" because it's not determined yet. But wait, the instructions say to consider only the worst lesion results. If there's no mention of malignancy, maybe it's "ei" (no). However, the example had "kyllä" when adenocarcinoma was mentioned. Here, there's no mention of cancer, so maybe "ei"? But the conclusion is pending, so maybe it's safer to put "NA" because the final assessment isn't done. The question is, does "pending" mean we can't determine malignancy yet, hence "NA"?

Third, Gleason score. The allowed format is "major+minor=sum" or "NA" if benign. Since there's no mention of malignancy, and the conclusion is pending, the Gleason should be "NA".

Putting it all together: Sampletype is NA because the type isn't specified. Malignancy is NA because the report is pending. Gleason is NA as well. 

Wait, but the user said to take into account only the worst lesion's results. If there's no malignancy found yet, but the report is pending, maybe malignancy is "ei" (no) because there's no mention of cancer. But the example used "kyllä" when cancer was present. Here, since the conclusion isn't final, but the current findings don't mention cancer, maybe "ei" is correct. However, the instructions might consider pending as "NA" because the final determination isn't made. The example didn't have a pending case. So perhaps in this case, since the conclusion isn't final, malignancy is "NA". 

So the final JSON would be:

{
  "Sampletype": "NA",
  "Malignancy": "NA",
  "Gleason": "NA"
}

But let me check again. The sample type: the text says "edustavaa prostatakudosta sovituista paikoista". If this is a biopsy, but the term "biopsiasta" isn't used. The example used "biopsy" when "biopsiasta" was in the text. Here, it's not mentioned, so sampletype is "NA". 

Malignancy: since the report is pending and no malignancy is mentioned, but the presence of "rauhasrakenteita" (glandular structures) and "aaltoilevaa epiteeliä" (undulating epithelium) might be benign. However, without a conclusion, it's safer to put "NA" because the pathologist hasn't finalized the diagnosis. 

Gleason: definitely "NA" since no cancer is mentioned and the conclusion is pending.
</think>

```json
{
  "Sampletype": "NA",
  "Malignancy": "NA",
  "Gleason": "NA"
}
```